Format

Send to

Choose Destination
Expert Opin Ther Targets. 2003 Feb;7(1):19-34.

Metalloproteinases: their role in arthritis and potential as therapeutic targets.

Author information

1
School of Biological Sciences, University of, East Anglia, Norwich, NR4 7TJ, UK. i.clark@uea.ac.uk

Abstract

Irreversible degradation of articular cartilage is a major feature of the arthritides, and its prevention is a therapeutic goal which has been difficult to achieve. Enzymes from the matrix metalloproteinase and ADAMTS (a disintegrin, a metalloproteinase, and thrombospondin motif) families are key mediators of cartilage extracellular matrix destruction. Inhibition of metalloproteinase activity is therefore a conceptually attractive therapeutic strategy, although clinical efficacy has not yet been demonstrated. This review outlines the biology behind metalloproteinases as drug targets in the arthritides, and poses important questions for the future design of such therapies.

PMID:
12556200
DOI:
10.1517/14728222.7.1.19
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center